Correlation Between GlaxoSmithKline PLC and Lyxor BEL

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Lyxor BEL at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Lyxor BEL into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Lyxor BEL 20, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Lyxor BEL and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Lyxor BEL. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Lyxor BEL.

Diversification Opportunities for GlaxoSmithKline PLC and Lyxor BEL

-0.05
  Correlation Coefficient

Good diversification

The 3 months correlation between GlaxoSmithKline and Lyxor is -0.05. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Lyxor BEL 20 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lyxor BEL 20 and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Lyxor BEL. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lyxor BEL 20 has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Lyxor BEL go up and down completely randomly.

Pair Corralation between GlaxoSmithKline PLC and Lyxor BEL

Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to under-perform the Lyxor BEL. In addition to that, GlaxoSmithKline PLC is 2.07 times more volatile than Lyxor BEL 20. It trades about -0.23 of its total potential returns per unit of risk. Lyxor BEL 20 is currently generating about -0.06 per unit of volatility. If you would invest  6,407  in Lyxor BEL 20 on August 30, 2024 and sell it today you would lose (128.00) from holding Lyxor BEL 20 or give up 2.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

GlaxoSmithKline PLC ADR  vs.  Lyxor BEL 20

 Performance 
       Timeline  
GlaxoSmithKline PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GlaxoSmithKline PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Lyxor BEL 20 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Lyxor BEL 20 are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Even with relatively invariable essential indicators, Lyxor BEL is not utilizing all of its potentials. The newest stock price agitation, may contribute to short-term losses for the retail investors.

GlaxoSmithKline PLC and Lyxor BEL Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GlaxoSmithKline PLC and Lyxor BEL

The main advantage of trading using opposite GlaxoSmithKline PLC and Lyxor BEL positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Lyxor BEL can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lyxor BEL will offset losses from the drop in Lyxor BEL's long position.
The idea behind GlaxoSmithKline PLC ADR and Lyxor BEL 20 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Other Complementary Tools

Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Global Correlations
Find global opportunities by holding instruments from different markets
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Insider Screener
Find insiders across different sectors to evaluate their impact on performance